table of content
1 Introduction to Research & Analysis Reports
1.1 Next-Generation Immunology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next-Generation Immunology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next-Generation Immunology Drugs Overall Market Size
2.1 Global Next-Generation Immunology Drugs Market Size: 2023 VS 2030
2.2 Global Next-Generation Immunology Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next-Generation Immunology Drugs Players in Global Market
3.2 Top Global Next-Generation Immunology Drugs Companies Ranked by Revenue
3.3 Global Next-Generation Immunology Drugs Revenue by Companies
3.4 Top 3 and Top 5 Next-Generation Immunology Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Next-Generation Immunology Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next-Generation Immunology Drugs Players in Global Market
3.6.1 List of Global Tier 1 Next-Generation Immunology Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Next-Generation Immunology Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Next-Generation Immunology Drugs Market Size Markets, 2023 & 2030
4.1.2 Cell Therapy
4.1.3 Small Molecule Drug
4.1.4 Others
4.2 By Type - Global Next-Generation Immunology Drugs Revenue & Forecasts
4.2.1 By Type - Global Next-Generation Immunology Drugs Revenue, 2019-2024
4.2.2 By Type - Global Next-Generation Immunology Drugs Revenue, 2025-2030
4.2.3 By Type - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next-Generation Immunology Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Next-Generation Immunology Drugs Revenue & Forecasts
5.2.1 By Application - Global Next-Generation Immunology Drugs Revenue, 2019-2024
5.2.2 By Application - Global Next-Generation Immunology Drugs Revenue, 2025-2030
5.2.3 By Application - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Next-Generation Immunology Drugs Market Size, 2023 & 2030
6.2 By Region - Global Next-Generation Immunology Drugs Revenue & Forecasts
6.2.1 By Region - Global Next-Generation Immunology Drugs Revenue, 2019-2024
6.2.2 By Region - Global Next-Generation Immunology Drugs Revenue, 2025-2030
6.2.3 By Region - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Next-Generation Immunology Drugs Revenue, 2019-2030
6.3.2 US Next-Generation Immunology Drugs Market Size, 2019-2030
6.3.3 Canada Next-Generation Immunology Drugs Market Size, 2019-2030
6.3.4 Mexico Next-Generation Immunology Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Next-Generation Immunology Drugs Revenue, 2019-2030
6.4.2 Germany Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.3 France Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.4 U.K. Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.5 Italy Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.6 Russia Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.8 Benelux Next-Generation Immunology Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Next-Generation Immunology Drugs Revenue, 2019-2030
6.5.2 China Next-Generation Immunology Drugs Market Size, 2019-2030
6.5.3 Japan Next-Generation Immunology Drugs Market Size, 2019-2030
6.5.4 South Korea Next-Generation Immunology Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Next-Generation Immunology Drugs Market Size, 2019-2030
6.5.6 India Next-Generation Immunology Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Next-Generation Immunology Drugs Revenue, 2019-2030
6.6.2 Brazil Next-Generation Immunology Drugs Market Size, 2019-2030
6.6.3 Argentina Next-Generation Immunology Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next-Generation Immunology Drugs Revenue, 2019-2030
6.7.2 Turkey Next-Generation Immunology Drugs Market Size, 2019-2030
6.7.3 Israel Next-Generation Immunology Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Next-Generation Immunology Drugs Market Size, 2019-2030
6.7.5 UAE Next-Generation Immunology Drugs Market Size, 2019-2030
7 Next-Generation Immunology Drugs Companies Profiles
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Summary
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc Next-Generation Immunology Drugs Major Product Offerings
7.1.4 Pfizer Inc Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.1.5 Pfizer Inc Key News & Latest Developments
7.2 Abbvie Inc.
7.2.1 Abbvie Inc. Company Summary
7.2.2 Abbvie Inc. Business Overview
7.2.3 Abbvie Inc. Next-Generation Immunology Drugs Major Product Offerings
7.2.4 Abbvie Inc. Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.2.5 Abbvie Inc. Key News & Latest Developments
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Company Summary
7.3.2 Johnson and Johnson Business Overview
7.3.3 Johnson and Johnson Next-Generation Immunology Drugs Major Product Offerings
7.3.4 Johnson and Johnson Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.3.5 Johnson and Johnson Key News & Latest Developments
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Company Summary
7.4.2 F. Hoffmann-La Roche Ltd. Business Overview
7.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.4.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.5 Amgen Inc.
7.5.1 Amgen Inc. Company Summary
7.5.2 Amgen Inc. Business Overview
7.5.3 Amgen Inc. Next-Generation Immunology Drugs Major Product Offerings
7.5.4 Amgen Inc. Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.5.5 Amgen Inc. Key News & Latest Developments
7.6 Novartis AG
7.6.1 Novartis AG Company Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Next-Generation Immunology Drugs Major Product Offerings
7.6.4 Novartis AG Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.6.5 Novartis AG Key News & Latest Developments
7.7 Astellas Pharma Inc.
7.7.1 Astellas Pharma Inc. Company Summary
7.7.2 Astellas Pharma Inc. Business Overview
7.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Major Product Offerings
7.7.4 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.7.5 Astellas Pharma Inc. Key News & Latest Developments
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Company Summary
7.8.2 Bristol-Myers Squibb Company Business Overview
7.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Major Product Offerings
7.8.4 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.8.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Company Summary
7.9.2 Merck & Co., Inc. Business Overview
7.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Major Product Offerings
7.9.4 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.9.5 Merck & Co., Inc. Key News & Latest Developments
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Company Summary
7.10.2 Eli Lilly and Company Business Overview
7.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Major Product Offerings
7.10.4 Eli Lilly and Company Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.10.5 Eli Lilly and Company Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
